𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Results of the PETHEMA ALL-96 trial in elderly patients with Philadelphia chromosome-negative acute lymphoblastic leukemia

✍ Scribed by Juan-Manuel Sancho; Josep-Maria Ribera; Blanca Xicoy; Mireia Morgades; Albert Oriol; Mar Tormo; Eloy del Potro; Guillermo Debén; Eugenia Abella; Concepción Bethencourt; Xavier Ortín; Salut Brunet; Fernando Ortega-Rivas; Andrés Novo; Ramón López; Jesús-María Hernández-Rivas; Miguel-Angel Sanz; Evarist Feliu; on behalf of the PETHEMA Group; Barcelona; Spain


Book ID
114794111
Publisher
John Wiley and Sons
Year
2006
Tongue
English
Weight
614 KB
Volume
0
Category
Article
ISSN
0902-4441

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Imatinib compared with chemotherapy as f
✍ Oliver G. Ottmann; Barbara Wassmann; Heike Pfeifer; Aristoteles Giagounidis; Mat 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 173 KB

## Abstract ## BACKGROUND Elderly patients with Philadelphia chromosome‐positive acute lymphoblastic leukemia (Ph+ALL) have a poor prognosis, with a low complete remission (CR) rate, high induction mortality, and short remission duration. Imatinib (IM) has a favorable toxicity profile but limited